Bright Minds Biosciences to participate in FPWR Research Symposium, PWS Family Conference

DRUG•2026-09-30

Bright Minds Biosciences will participate in the FPWR 2026 Research Symposium on Oct. 7-8 and attend the PWS Family Conference on Oct. 9-10 in Philadelphia as its Phase 2a NOVA trial of BMB-101 progresses.

1. Conference participation

Bright Minds Biosciences plans to engage with the Prader-Willi Syndrome community at the FPWR 2026 Research Symposium on Oct. 7-8 and the PWS Family Conference on Oct. 9-10 in Philadelphia.

Bright Minds Biosciences to participate in FPWR Research Symposium, PWS Family Conference

1. Conference participation

Related News

BNP Paribas mobilises capital markets to fund blue economy initiatives

JLL arranges sale of Austin’s Lavaca Plaza office building to Riverside

Clipper Realty COO Jacob Bistricer acquires $246,225 in common shares

Shrugging off a volatile September, markets shuffle into Q4

Akanda net loss widens 667% to $6.25 million in six months ended June 30, 2026; revenue totals $404,394